{"product_id":"principles-and-practice-of-transplant-infectious-diseases-9781493990320","title":"Principles and Practice of Transplant Infectious Diseases","description":"\u003cb\u003eBook Synopsis\u003c\/b\u003e\u003cbr\u003e\u003cp\u003eThis comprehensive volume provides a platform from which both major and minor infectious diseases related issues are addressed in-depth among this highly susceptible population.  The book begins with an overview of infections in various modalities. This is followed by chapters on clinical disorders, etiologic agents, therapeutics, and infection prevention. Chapters include easy-to-follow figures and tables, radiologic images, and pictorial demonstrations of various disease states to familiarize and reacquaint the transplant clinicians and surgeons in practice and training, and those belonging to subspecialties providing supportive care for these patients. Discussions to enumerate the noninfectious causes that mimic infectious diseases; clinical relevance and effective utility of existing and emerging diagnostic tools are presented throughout the book. Authored by leaders in their fields, this book is the go-to reference for management of patients undergoing hematopoietic and so\u003cbr\u003e\u003cbr\u003e\u003cb\u003eTable of Contents\u003c\/b\u003e\u003cbr\u003e\u003c\/p\u003e\u003cp\u003e\u003c\/p\u003e\u003cp\u003e\u003c\/p\u003e\u003cp\u003eChapter 1    \u003c\/p\u003e  \u003cp\u003eInfections in Transplantation:  Introduction and Overview \u003c\/p\u003e  \u003cp\u003eAmar Safdar\u003c\/p\u003e   \u003cp\u003e\u003c\/p\u003e  \u003cp\u003eChapter 2 \u003cb\u003e    \u003c\/b\u003e\u003c\/p\u003e  \u003cp\u003eInfections in Heart, Lung, and Heart-Lung Transplantation\u003c\/p\u003e  \u003cp\u003eAndrés F. Henao-Martínez and José G. Montoya \u003csup\u003e \u003c\/sup\u003e\u003c\/p\u003e  \u003cp\u003e\u003csup\u003e \u003c\/sup\u003e\u003c\/p\u003e  \u003cp\u003eChapter 3\u003cb\u003e    \u003c\/b\u003e\u003c\/p\u003e  \u003cp\u003eInfections in Liver Transplantation\u003c\/p\u003e  \u003cp\u003eB. Sharmila Mohanraj, Amol S. Rangnekar, and Joseph G. Timpone, Jr\u003c\/p\u003e  \u003cp\u003e \u003c\/p\u003e  \u003cp\u003eChapter 4\u003cb\u003e    \u003c\/b\u003e\u003c\/p\u003e  \u003cp\u003eInfections in Kidney and Pancreas Transplantation\u003c\/p\u003e  \u003cp\u003eMegan K. Morales, Matthew Cooper, Peter Abrams, and Joseph G. Timpone, Jr\u003c\/p\u003e  \u003cp\u003e \u003c\/p\u003e  \u003cp\u003eChapter 5\u003cb\u003e    \u003c\/b\u003e\u003c\/p\u003e  \u003cp\u003eInfections in Intestinal and Multivisceral Transplantation\u003c\/p\u003e  \u003cp\u003eRaffaele Girlanda, Joseph G. Timpone, Jr, Kevin M. Soriano, and Thomas M. Fishbein\u003c\/p\u003e  \u003cp\u003e \u003c\/p\u003e  \u003cp\u003e \u003c\/p\u003e  \u003cp\u003eChapter 6\u003cb\u003e    \u003c\/b\u003e\u003c\/p\u003e  \u003cp\u003eInfections in Limbs, Integuments, and Face Transplantation\u003c\/p\u003e  \u003cp\u003eJustin M. Broyles and Chad R. Gordon\u003c\/p\u003e  \u003cp\u003e \u003c\/p\u003e  Chapter 7\u003cb\u003e    \u003c\/b\u003e\u003cp\u003e\u003c\/p\u003e  \u003cp\u003ePrinciples of Hematopoietic Stem Cell Transplantation\u003c\/p\u003e  \u003cp\u003eMichelle Limei Poon, Richard E. Champlin, and Partow Kebriaei\u003c\/p\u003e  \u003cp\u003e \u003c\/p\u003e  \u003cp\u003eChapter 8\u003cb\u003e    \u003c\/b\u003e\u003c\/p\u003e  \u003cp\u003eInfections in Pediatric Transplant Recipients\u003c\/p\u003e  \u003cp\u003eAspasia Katragkou,\u003csup\u003e \u003c\/sup\u003eLucy O’Connor, Emmanuel Roilides, and Thomas J. Walsh\u003c\/p\u003e   \u003cp\u003e\u003c\/p\u003e  \u003cp\u003eChapter 9\u003cb\u003e    \u003c\/b\u003e\u003c\/p\u003e  \u003cp\u003eFebrile Neutropenia in Transplant Recipients\u003c\/p\u003e  \u003cp\u003eLior Nesher\u003csup\u003e \u003c\/sup\u003eand Kenneth V. I. Rolston\u003csup\u003e\u003c\/sup\u003e\u003c\/p\u003e  \u003cp\u003e \u003c\/p\u003e  \u003cp\u003eChapter 10\u003cb\u003e    \u003c\/b\u003e\u003c\/p\u003e  \u003cp\u003eCytopenias in Transplant Patients\u003c\/p\u003e  \u003cp\u003eMaura Barry, Sunandana Chandra, and Kenneth B. Hymes\u003c\/p\u003e  \u003cp\u003e \u003c\/p\u003e  \u003cp\u003eChapter 11\u003cb\u003e    \u003c\/b\u003e\u003c\/p\u003e  \u003cp\u003eInfections in Allogeneic Stem Cell Transplantation\u003c\/p\u003e  \u003cp\u003eMarcus R. Pereira, Stephanie M. Pouch, and Brian Scully\u003c\/p\u003e  \u003cp\u003e \u003c\/p\u003e  \u003cp\u003eChapter 12\u003cb\u003e    \u003c\/b\u003e\u003c\/p\u003e  \u003cp\u003eComplications Arising from Preparatory Conditioning Regimens for Stem Cell Transplantation \u003c\/p\u003e  Jasmine Zain and Merav Bar\u003cp\u003e\u003c\/p\u003e  \u003cp\u003e \u003c\/p\u003e  \u003cp\u003eChapter 13\u003cb\u003e    \u003c\/b\u003e\u003c\/p\u003e  \u003cp\u003eIntravascular Catheter and Implantable Device Infections in Transplant Patients\u003c\/p\u003e  \u003cp\u003eNasia Safdar, Cybele Lara R. Abad, and Dennis G. Maki\u003c\/p\u003e  \u003cp\u003e \u003c\/p\u003e  \u003cp\u003eChapter 14\u003cb\u003e    \u003c\/b\u003e\u003c\/p\u003e  Surgical Site Infections: Wound and Stump Infections\u003cp\u003e\u003c\/p\u003e  \u003cp\u003eNasia Safdar, Sara A. M. Zerbel, and Elizabeth Ann Misch\u003c\/p\u003e  \u003cp\u003e \u003c\/p\u003e  \u003cp\u003eChapter 15\u003cb\u003e    \u003c\/b\u003e\u003c\/p\u003e  \u003cp\u003eEndovascular Infections and Endocarditis \u003c\/p\u003e  \u003cp\u003eWalter Zingg and Didier Pittet\u003c\/p\u003e  \u003cp\u003e \u003c\/p\u003e  \u003cp\u003eChapter 16\u003cb\u003e    \u003c\/b\u003e\u003c\/p\u003e  \u003cp\u003eGastrointestinal Infections and \u003ci\u003eClostridium difficile \u003c\/i\u003eInfection\u003c\/p\u003e  \u003cp\u003eStephen Harold and Herbert L. DuPont\u003c\/p\u003e  \u003cp\u003e \u003c\/p\u003e  \u003cp\u003eChapter 17    \u003c\/p\u003e  \u003cp\u003eHepatobiliary Tract Infections\u003c\/p\u003e  \u003cp\u003eJonathan Merola, Robert M. Mocharla, Alexander Z. Jow, Samuel H. Sigal, and Amar Safdar\u003c\/p\u003e  \u003cp\u003e \u003c\/p\u003e  \u003cp\u003eChapter 18\u003cb\u003e    \u003c\/b\u003e\u003c\/p\u003e  \u003cp\u003eOcular Infections in Transplant Patients\u003c\/p\u003e  \u003cp\u003eAnn-Marie Lobo,\u003csup\u003e \u003c\/sup\u003eLucia Sobrin,\u003csup\u003e \u003c\/sup\u003eand\u003csup\u003e \u003c\/sup\u003eMarlene L. Durand\u003csup\u003e\u003c\/sup\u003e\u003c\/p\u003e  \u003cp\u003e \u003c\/p\u003e  Chapter 19\u003cb\u003e    \u003c\/b\u003e\u003cp\u003e\u003c\/p\u003e  \u003cp\u003eIntracranial, Spinal, and Paraspinal Infections in the Transplant Recipient\u003c\/p\u003e  \u003cp\u003eMatthew W. McCarthy, Axel Rosengart and Thomas J. Walsh\u003c\/p\u003e  \u003cp\u003e \u003c\/p\u003e  \u003cp\u003eChapter 20\u003cb\u003e    \u003c\/b\u003e\u003c\/p\u003e  \u003cp\u003eRespiratory Tract Infections: Sinusitis, Bronchitis, and Pneumonia \u003c\/p\u003e  \u003cp\u003eBenjamin A. Miko, Marcus R. Pereira, and Amar Safdar\u003c\/p\u003e   \u003cp\u003e\u003c\/p\u003e  \u003cp\u003eChapter 21\u003cb\u003e    \u003c\/b\u003e\u003c\/p\u003e  \u003cp\u003eRespiratory Tract Diseases That May Be Mistaken For Infection                              \u003c\/p\u003e  Robert M. Kotloff, Burton F. Dickey, and Nicholas Vander Els\u003csup\u003e\u003c\/sup\u003e\u003cp\u003e\u003c\/p\u003e  \u003cp\u003e \u003c\/p\u003e  \u003cp\u003eChapter 22\u003cb\u003e    \u003c\/b\u003e\u003c\/p\u003e  \u003cp\u003eSkin and Soft Tissue Infection in Transplant Recipients\u003c\/p\u003e  \u003cp\u003eRobert G. Micheletti and Carrie L. Kovarik\u003c\/p\u003e  \u003cp\u003e \u003c\/p\u003e  \u003cp\u003eChapter 23\u003cb\u003e    \u003c\/b\u003e\u003c\/p\u003e  \u003cp\u003eCutaneous Lesions that Mimic Infection in Transplant Patients \u003c\/p\u003e  \u003cp\u003eAna Ciurea and Sharon Hymes\u003c\/p\u003e  \u003cp\u003e \u003c\/p\u003e  \u003cp\u003eChapter 24\u003cb\u003e    \u003c\/b\u003e\u003c\/p\u003e  \u003cp\u003eStaphylococcus, Streptococcus, and Enterococcus \u003c\/p\u003e  \u003cp\u003eAmar Safdar and Donald Armstrong\u003c\/p\u003e  \u003cp\u003e \u003c\/p\u003e  \u003cp\u003eChapter 25\u003cb\u003e    \u003c\/b\u003e\u003c\/p\u003e  \u003cp\u003e\u003ci\u003eEnterobacteriaceae\u003c\/i\u003e in Transplantation\u003c\/p\u003e  \u003cp\u003eKathryn Whitaker, Valerie Cluzet, and Emily A. Blumberg\u003c\/p\u003e  \u003cp\u003e \u003c\/p\u003e  \u003cp\u003eChapter 26\u003cb\u003e   \u003c\/b\u003e\u003c\/p\u003e  \u003cp\u003ePseudomonas, Stenotrophomonas, Acinetobacter, and Other Non-Fermentative Gram-Negative Bacteria \u0026amp; Medically Important Anaerobic Bacteria in Transplant Recipients \u003c\/p\u003e  \u003cp\u003eKenneth V.I. Rolston and Amar Safdar\u003c\/p\u003e  \u003cp\u003e \u003c\/p\u003e  \u003cp\u003eChapter 27\u003cb\u003e    \u003c\/b\u003e\u003c\/p\u003e  \u003cp\u003eNocardiosis and Actinomycosis\u003c\/p\u003e  \u003cp\u003eHeather E. Clauss and Bennett Lorber\u003c\/p\u003e  \u003cp\u003e \u003c\/p\u003e  \u003cp\u003eChapter 28\u003cb\u003e    \u003c\/b\u003e\u003c\/p\u003e  \u003cp\u003eListeriosis\u003c\/p\u003e  \u003cp\u003eHeather E. Clauss and Bennett Lorber\u003c\/p\u003e  \u003cp\u003e \u003c\/p\u003e  \u003cp\u003eChapter 29\u003cb\u003e    \u003c\/b\u003e\u003c\/p\u003e  \u003cp\u003eTuberculosis \u003c\/p\u003e  \u003cp\u003eCynthia Portal-Celhay and Jennifer A. Philips\u003c\/p\u003e  \u003cp\u003e \u003c\/p\u003e  \u003cp\u003eChapter 30\u003cb\u003e    \u003c\/b\u003e\u003c\/p\u003e  \u003cp\u003eNontuberculous Mycobacterial Disease in Transplant Recipients \u003c\/p\u003e  \u003cp\u003eJulie V. Philley, Amar Safdar, and Charles L. Daley \u003c\/p\u003e  \u003cp\u003e \u003c\/p\u003e   \u003cp\u003e\u003c\/p\u003e  \u003cp\u003e \u003c\/p\u003e  \u003cp\u003eChapter 31\u003cb\u003e    \u003c\/b\u003e\u003c\/p\u003e  \u003cp\u003eInvasive Fungal Disease in the Transplant Population: An Overview\u003c\/p\u003e  Jennifer L. Saullo,  John R. Perfect, and Barbara D. Alexander\u003cp\u003e\u003c\/p\u003e  \u003cp\u003e \u003c\/p\u003e  \u003cp\u003eChapter 32\u003cb\u003e    \u003c\/b\u003e\u003c\/p\u003e  \u003cp\u003eCandida Infections in Hematopoietic and Solid Organ Transplant Recipients\u003c\/p\u003e  \u003cp\u003eAlison G. Freifeld and Carol A. Kauffman\u003c\/p\u003e  \u003cp\u003e \u003c\/p\u003e  \u003cp\u003eChapter 33\u003cb\u003e    \u003c\/b\u003e\u003c\/p\u003e  \u003cp\u003eAspergillosis\u003c\/p\u003e  \u003cp\u003eMichael J. Satlin, Samantha E. Jacobs, and Thomas J. Walsh\u003csup\u003e\u003c\/sup\u003e\u003c\/p\u003e  \u003cp\u003e \u003c\/p\u003e  \u003cp\u003eChapter 34    \u003c\/p\u003e  \u003cp\u003eMucormycosis \u003c\/p\u003e  \u003cp\u003eBrad Spellberg and Johan Maertens\u003csup\u003e\u003c\/sup\u003e\u003c\/p\u003e  \u003cp\u003e \u003c\/p\u003e  \u003cp\u003eChapter 35\u003cb\u003e   \u003c\/b\u003e\u003c\/p\u003e  \u003cp\u003eCryptococcus Infections in Transplant Recipients\u003c\/p\u003e  \u003cp\u003eRaymund R. Razonable\u003cb\u003e \u003c\/b\u003eand\u003cb\u003e \u003c\/b\u003ePearlie P. Chong\u003c\/p\u003e  \u003cp\u003e \u003c\/p\u003e  Chapter 36\u003cb\u003e    \u003c\/b\u003e\u003cp\u003e\u003c\/p\u003e  \u003cp\u003eHistoplasmosis, Coccidioidomycosis and Diseases due to Other Endemic Fungi in Transplant Recipients\u003c\/p\u003e  \u003cp\u003ePascalis Vergidis, Chadi A. Hage, and L. Joseph Wheat\u003c\/p\u003e  \u003cp\u003e \u003c\/p\u003e  \u003cp\u003eChapter 37\u003cb\u003e    \u003c\/b\u003e\u003c\/p\u003e  \u003cp\u003eCytomegalovirus \u003c\/p\u003e  \u003cp\u003eAmar Safdar and Donald Armstrong\u003c\/p\u003e  \u003cp\u003e \u003c\/p\u003e  \u003cp\u003eChapter 38\u003cb\u003e    \u003c\/b\u003e\u003c\/p\u003e  \u003cp\u003eEpstein-Barr Virus Infection and Post-Transplant Lymphoproliferative Disease\u003c\/p\u003e  \u003cp\u003eBenjamin E. Gewurz, Amy Sievers, David M.Weinstock, Sheila Mitsuma and Amar Safdar \u003c\/p\u003e  \u003cp\u003e \u003c\/p\u003e  \u003cp\u003eChapter 39\u003cb\u003e    \u003c\/b\u003e\u003c\/p\u003e  Herpes Simplex Viruses 1 and 2, Varicella Zoster Virus and Human Herpes Viruses 6, 7 and 8 in Transplant Recipients\u003cp\u003e\u003c\/p\u003e  \u003cp\u003eRaymund R. Razonable*\u003c\/p\u003e  \u003cp\u003e \u003c\/p\u003e  \u003cp\u003eChapter 40\u003cb\u003e    \u003c\/b\u003e\u003c\/p\u003e  \u003cp\u003eRespiratory Viral Infections in Transplant Recipients\u003c\/p\u003e  \u003cp\u003eCatherine Liu, Dora Y. Ho, and Michael Boeckh\u003csup\u003e\u003c\/sup\u003e\u003c\/p\u003e   \u003cp\u003e\u003c\/p\u003e  \u003cp\u003eChapter 41\u003cb\u003e    \u003c\/b\u003e\u003c\/p\u003e  \u003cp\u003eHepatitis A, B, C \u003c\/p\u003e  \u003cp\u003eJonathan Merola, Alexander Z. Jow, and Samuel H. Sigal\u003c\/p\u003e   \u003cp\u003e\u003c\/p\u003e  \u003cp\u003eChapter 42\u003cb\u003e    \u003c\/b\u003e\u003c\/p\u003e  \u003cp\u003eEnterovirus Infection in Immunocompromised Hosts\u003c\/p\u003e  \u003cp\u003eJoanna Schaenman, Dora Y. Ho, Lindsey R. Baden, and Amar Safdar\u003c\/p\u003e  \u003cp\u003e \u003c\/p\u003e  \u003cp\u003eChapter 43\u003cb\u003e    \u003c\/b\u003e\u003c\/p\u003e  \u003cp\u003eParvovirus B19  \u003c\/p\u003e  \u003cp\u003eMorgan Hakki and Lynne Strasfeld\u003c\/p\u003e  \u003cp\u003e \u003c\/p\u003e  \u003cp\u003eChapter 44\u003cb\u003e    \u003c\/b\u003e\u003c\/p\u003e  \u003cp\u003eWest Nile Virus in Immunocompromised Hosts  \u003c\/p\u003e  Dora Y. Ho, Joanna M.D. Schaenman, and Lindsey R. Baden \u003cp\u003e\u003c\/p\u003e  \u003cp\u003e \u003c\/p\u003e  \u003cp\u003eChapter 45\u003cb\u003e    \u003c\/b\u003e\u003c\/p\u003e  Rare and Emerging Viral Infections in the Transplant Population\u003cp\u003e\u003c\/p\u003e  \u003cp\u003eSusanna K. Tan, Jesse J. Waggoner, and Stan Deresinski\u003c\/p\u003e  \u003cp\u003e \u003c\/p\u003e  \u003cp\u003eChapter 46\u003cb\u003e    \u003c\/b\u003e\u003c\/p\u003e  \u003cp\u003eParasitic Infections in Transplant Recipients: Toxoplasmosis, Strongyloidiasis and Other Parasites \u003c\/p\u003e  \u003cp\u003eBrian G. Blackburn and José G. Montoya\u003c\/p\u003e  \u003cp\u003e \u003c\/p\u003e  \u003cp\u003eChapter 47    \u003c\/p\u003e  \u003cp\u003eImpacts and Challenges of Advanced Diagnostic Assays for Transplant Infectious Diseases\u003c\/p\u003e  \u003cp\u003eN. Esther Babady,\u003csup\u003e \u003c\/sup\u003eYeon Joo Lee, Genovefa Papanicolaou,\u003csup\u003e \u003c\/sup\u003eand Yi-Wei Tang\u003csup\u003e\u003c\/sup\u003e\u003c\/p\u003e  \u003cp\u003e \u003c\/p\u003e  Chapter 48    \u003cp\u003e\u003c\/p\u003e  \u003cp\u003eDiagnosis of Systemic Fungal Diseases\u003c\/p\u003e  \u003cp\u003eSimon F. Dufresne, Kieren A. Marr and Shmuel Shoham\u003c\/p\u003e  \u003cp\u003e \u003c\/p\u003e  Chapter 49\u003cb\u003e    \u003c\/b\u003e\u003cp\u003e\u003c\/p\u003e  \u003cp\u003eViral Diagnostics \u003c\/p\u003e  \u003cp\u003eRobin K. Avery and Belinda Yen-Lieberman\u003c\/p\u003e  \u003cp\u003e \u003c\/p\u003e  Chapter 50\u003cb\u003e    \u003c\/b\u003e\u003cp\u003e\u003c\/p\u003e  \u003cp\u003eAntibiotic Consideration in Transplant Recipients \u003c\/p\u003e  \u003cp\u003eJerry Altshuler, Samuel L. Aitken, Melanie Maslow, John Papadopoulos, and Amar Safdar\u003c\/p\u003e  \u003cp\u003e \u003c\/p\u003e  \u003cp\u003eChapter 51\u003cb\u003e    \u003c\/b\u003e\u003c\/p\u003e  \u003cp\u003ePharmacokinetics and Pharmacodynamics of Antibiotics in Transplant Patients \u003c\/p\u003e  \u003cp\u003eKelly E. Schoeppler, Scott W. Mueller, and Gerard R. Barber\u003c\/p\u003e  \u003cp\u003e \u003c\/p\u003e  \u003cp\u003eChapter 52\u003cb\u003e    \u003c\/b\u003e\u003c\/p\u003e  \u003cp\u003eAntifungal Consideration for Transplant Recipients\u003c\/p\u003e  \u003cp\u003eYanina Dubrovskaya, Man Yee Merl, David S. Perlin, and Amar Safdar\u003c\/p\u003e  \u003cp\u003e \u003c\/p\u003e  \u003cp\u003eChapter 53\u003cb\u003e    \u003c\/b\u003e\u003c\/p\u003e  \u003cp\u003eImmunomodulatory Properties of Antifungal Agents on Immune Functions of the Host \u003c\/p\u003e  \u003cp\u003eMaria Simitsopoulou and Emmanuel Roilides\u003c\/p\u003e  \u003cp\u003e \u003c\/p\u003e  \u003cp\u003eChapter 54\u003cb\u003e    \u003c\/b\u003e\u003c\/p\u003e  \u003cp\u003eAntiviral Consideration for Transplantation Including Drug Resistance\u003c\/p\u003e  \u003cp\u003eSunwen Chou and Nell S. Lurain \u003c\/p\u003e  \u003cp\u003e \u003c\/p\u003e  \u003cp\u003eChapter 55\u003cb\u003e    \u003c\/b\u003e\u003c\/p\u003e  \u003cp\u003ePharmacokinetics and Pharmacodynamics of Antiviral Drugs in Special Population\u003c\/p\u003e  \u003cp\u003eMarco R. Scipione* and John Papadopoulos \u003c\/p\u003e  \u003cp\u003e \u003c\/p\u003e  \u003cp\u003eChapter 56\u003cb\u003e    \u003c\/b\u003e\u003c\/p\u003e  Anti-Mycobacterial Consideration in Transplantation Including Drug Non-Susceptibility and Resistance: Tuberculosis and Nontuberculous Mycobacterial Disease\u003cp\u003e\u003c\/p\u003e  \u003cp\u003eJulie V. Philley and David E. Griffith \u003c\/p\u003e  \u003cp\u003e \u003c\/p\u003e  \u003cp\u003e \u003c\/p\u003e  \u003cp\u003e \u003c\/p\u003e  \u003cp\u003eChapter 57\u003cb\u003e    \u003c\/b\u003e\u003c\/p\u003e  \u003cp\u003eAdaptive Immunotherapy for Opportunistic Infections\u003c\/p\u003e  \u003cp\u003eAspasia Katragkou, Thomas J. Walsh, and Emmanuel Roilides  \u003c\/p\u003e  \u003cp\u003e\u003cb\u003e \u003c\/b\u003e\u003c\/p\u003e  \u003cp\u003eChapter 58\u003cb\u003e    \u003c\/b\u003e\u003c\/p\u003e  Immunotherapy for Invasive Mold Disease in Transplant Patients – Dendritic Cell Immunotherapy, Interferon-gamma, Recombinant Myeloid Growth Factors, and Healthy Donor Granulocyte Transfusions\u003cp\u003e\u003c\/p\u003e  \u003cp\u003eWilliam K. Decker, Matthew M. Halpert, Vanaja Konduri, Dan Liang, Christopher N. Hampton, and Amar Safdar\u003c\/p\u003e  \u003cp\u003e \u003c\/p\u003e  \u003cp\u003eChapter 59\u003cb\u003e    \u003c\/b\u003e\u003c\/p\u003e  \u003cp\u003eAntimicrobial Stewardship: Considerations for a Transplant Center \u003c\/p\u003e  \u003cp\u003eSusan K. Seo\u003csup\u003e \u003c\/sup\u003eand Graeme N. Forrest\u003csup\u003e\u003c\/sup\u003e\u003c\/p\u003e  \u003cp\u003e \u003c\/p\u003e  Chapter 60\u003cb\u003e    \u003c\/b\u003e\u003cp\u003e\u003c\/p\u003e  \u003cp\u003eThe Use of Palliative Care in Organ Transplant Patients and End of Life Issues\u003c\/p\u003e  \u003cp\u003eJenny S. Ayala and Joseph Lowy\u003c\/p\u003e  \u003cp\u003e \u003c\/p\u003e  \u003cp\u003eChapter 61\u003cb\u003e    \u003c\/b\u003e\u003c\/p\u003e  \u003cp\u003eInfection Control Strategies in Transplant Populations\u003c\/p\u003e  \u003cp\u003eScott Cutro, Michael Phillips, and Harold W. Horowitz\u003c\/p\u003e   \u003cp\u003e\u003c\/p\u003e  \u003cp\u003eChapter 62\u003cb\u003e    \u003c\/b\u003e\u003c\/p\u003e  \u003cp\u003eTravel and Transplantation  \u003c\/p\u003e  \u003cp\u003eCamille Nelson Kotton and José G. Montoya\u003c\/p\u003e  \u003cp\u003e \u003c\/p\u003e  \u003cp\u003eChapter 63\u003cb\u003e    \u003c\/b\u003e\u003c\/p\u003e  \u003cp\u003eVaccination in Organ Transplant \u003c\/p\u003e  \u003cp\u003eLara Danziger-Isakov and Camille Nelson Kotton\u003c\/p\u003e  \u003cp\u003e \u003c\/p\u003e  \u003cp\u003eChapter 64\u003cb\u003e    \u003c\/b\u003e\u003c\/p\u003e  \u003cp\u003ePrevention of Fungal Disease\u003c\/p\u003e  \u003cp\u003eShirish Huprikar and John R. Wingard\u003c\/p\u003e  \u003cp\u003e \u003c\/p\u003e  \u003cp\u003eChapter 65\u003cb\u003e    \u003c\/b\u003e\u003c\/p\u003e  \u003cp\u003eAntimicrobial Drug Prophylaxis: Challenges and Controversies \u003c\/p\u003e  \u003cp\u003eGaurav Trikha, Marcio Nucci,\u003csup\u003e \u003c\/sup\u003eJohn R. Wingard and Amar Safdar\u003c\/p\u003e\u003cbr\u003e\u003cp\u003e\u003c\/p\u003e\u003cp\u003e\u003c\/p\u003e","brand":"Springer-Verlag New York Inc.","offers":[{"title":"Default Title","offer_id":53187788276055,"sku":"9781493990320","price":179.99,"currency_code":"GBP","in_stock":true}],"url":"https:\/\/bookcurl.com\/products\/principles-and-practice-of-transplant-infectious-diseases-9781493990320","provider":"Book Curl","version":"1.0","type":"link"}